
Brenda Libby Coleman
Examiner (ID: 16325)
| Most Active Art Unit | 1624 |
| Art Unit(s) | 1202, 2611, 1624, 1611 |
| Total Applications | 3154 |
| Issued Applications | 1970 |
| Pending Applications | 485 |
| Abandoned Applications | 741 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5748373
[patent_doc_number] => 20060111305
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-25
[patent_title] => 'Metabolites of certain [1,4]diazepino[6,7,1-ij]quinoline derivatives and methods of preparation and use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/267765
[patent_app_country] => US
[patent_app_date] => 2005-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 33946
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0111/20060111305.pdf
[firstpage_image] =>[orig_patent_app_number] => 11267765
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/267765 | Metabolites of certain [1,4]diazepino[6,7,1-ij]quinoline derivatives and methods of preparation and use thereof | Nov 3, 2005 | Abandoned |
Array
(
[id] => 8232993
[patent_doc_number] => 08198435
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-06-12
[patent_title] => 'Crystal form of N-benzoyl-staurosporine'
[patent_app_type] => utility
[patent_app_number] => 11/718029
[patent_app_country] => US
[patent_app_date] => 2005-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5934
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/198/08198435.pdf
[firstpage_image] =>[orig_patent_app_number] => 11718029
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/718029 | Crystal form of N-benzoyl-staurosporine | Nov 2, 2005 | Issued |
Array
(
[id] => 322662
[patent_doc_number] => 07517895
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-04-14
[patent_title] => 'Synthetic diazonamides'
[patent_app_type] => utility
[patent_app_number] => 11/264502
[patent_app_country] => US
[patent_app_date] => 2005-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 13438
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/517/07517895.pdf
[firstpage_image] =>[orig_patent_app_number] => 11264502
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/264502 | Synthetic diazonamides | Oct 30, 2005 | Issued |
Array
(
[id] => 5614439
[patent_doc_number] => 20060116367
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-01
[patent_title] => 'Novel [1,4]benzodiazepines as vasopressin V2 receptor antagonists'
[patent_app_type] => utility
[patent_app_number] => 11/260118
[patent_app_country] => US
[patent_app_date] => 2005-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15170
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0116/20060116367.pdf
[firstpage_image] =>[orig_patent_app_number] => 11260118
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/260118 | [1,4]benzodiazepines as vasopressin V2 receptor antagonists | Oct 26, 2005 | Issued |
Array
(
[id] => 5688983
[patent_doc_number] => 20060287298
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-21
[patent_title] => 'Pharmaceutical for treatment of neurological and neuropsychiatric disorders'
[patent_app_type] => utility
[patent_app_number] => 11/259583
[patent_app_country] => US
[patent_app_date] => 2005-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 21940
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0287/20060287298.pdf
[firstpage_image] =>[orig_patent_app_number] => 11259583
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/259583 | Pharmaceutical for treatment of neurological and neuropsychiatric disorders | Oct 25, 2005 | Abandoned |
Array
(
[id] => 5410901
[patent_doc_number] => 20090124800
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-14
[patent_title] => ' PROCESS FOR THE PREPARATION OF [1,4,5]-OXADIAZEPINE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 11/577805
[patent_app_country] => US
[patent_app_date] => 2005-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2450
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0124/20090124800.pdf
[firstpage_image] =>[orig_patent_app_number] => 11577805
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/577805 | PROCESS FOR THE PREPARATION OF [1,4,5]-OXADIAZEPINE DERIVATIVES | Oct 24, 2005 | Abandoned |
Array
(
[id] => 5814864
[patent_doc_number] => 20060084642
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-20
[patent_title] => 'Substituted imidazol[1,5-A][1,2,4]triazolo[1,5-D][1,4]benzodiazepine derivatives'
[patent_app_type] => utility
[patent_app_number] => 11/252025
[patent_app_country] => US
[patent_app_date] => 2005-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10155
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0084/20060084642.pdf
[firstpage_image] =>[orig_patent_app_number] => 11252025
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/252025 | Substituted imidazol[1,5-A][1,2,4]triazolo[1,5-D][1,4]benzodiazepine derivatives | Oct 16, 2005 | Issued |
Array
(
[id] => 5815274
[patent_doc_number] => 20060084801
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-20
[patent_title] => 'Halogen substituted imidazol[1,5-A][1,2,4]triazolo[1,5-D][1,4]benzodiazepine derivatives'
[patent_app_type] => utility
[patent_app_number] => 11/252026
[patent_app_country] => US
[patent_app_date] => 2005-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18193
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0084/20060084801.pdf
[firstpage_image] =>[orig_patent_app_number] => 11252026
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/252026 | Halogen substituted imidazol[1,5-A][1,2,4]triazolo[1,5-D][1,4]benzodiazepine derivatives | Oct 16, 2005 | Issued |
Array
(
[id] => 4670446
[patent_doc_number] => 20080045506
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-21
[patent_title] => 'Pyrrolidine Derivatives as Histamine Receptors Ligands'
[patent_app_type] => utility
[patent_app_number] => 11/576968
[patent_app_country] => US
[patent_app_date] => 2005-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35877
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0045/20080045506.pdf
[firstpage_image] =>[orig_patent_app_number] => 11576968
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/576968 | Pyrrolidine Derivatives as Histamine Receptors Ligands | Oct 12, 2005 | Abandoned |
Array
(
[id] => 4904552
[patent_doc_number] => 20080113966
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-15
[patent_title] => 'Cgrp Receptor Antagonists'
[patent_app_type] => utility
[patent_app_number] => 11/665523
[patent_app_country] => US
[patent_app_date] => 2005-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 69642
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20080113966.pdf
[firstpage_image] =>[orig_patent_app_number] => 11665523
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/665523 | CGRP receptor antagonists | Oct 11, 2005 | Issued |
Array
(
[id] => 5727548
[patent_doc_number] => 20060058309
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-16
[patent_title] => 'Respiratory syncytial virus replication inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/247392
[patent_app_country] => US
[patent_app_date] => 2005-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25101
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20060058309.pdf
[firstpage_image] =>[orig_patent_app_number] => 11247392
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/247392 | Respiratory syncytial virus replication inhibitors | Oct 10, 2005 | Issued |
Array
(
[id] => 5716144
[patent_doc_number] => 20060079507
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-13
[patent_title] => 'Substituted imidazo[1,5-a][1,2,4]triazolo[1,5-d][1,4]benzodiazepine derivatives'
[patent_app_type] => utility
[patent_app_number] => 11/245736
[patent_app_country] => US
[patent_app_date] => 2005-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16037
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0079/20060079507.pdf
[firstpage_image] =>[orig_patent_app_number] => 11245736
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/245736 | Substituted imidazo [1,5-a][1,2,4]triazolo[1,5-d][1,4]benzodiazepine derivatives | Oct 6, 2005 | Issued |
Array
(
[id] => 4461107
[patent_doc_number] => 07879882
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-02-01
[patent_title] => 'Thiazolyl mglur5 antagonists and methods for their use'
[patent_app_type] => utility
[patent_app_number] => 11/664902
[patent_app_country] => US
[patent_app_date] => 2005-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11639
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/879/07879882.pdf
[firstpage_image] =>[orig_patent_app_number] => 11664902
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/664902 | Thiazolyl mglur5 antagonists and methods for their use | Oct 5, 2005 | Issued |
Array
(
[id] => 5881474
[patent_doc_number] => 20060030557
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-09
[patent_title] => 'Substituted pyridines having antiangiogenic activity'
[patent_app_type] => utility
[patent_app_number] => 11/244481
[patent_app_country] => US
[patent_app_date] => 2005-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38623
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0030/20060030557.pdf
[firstpage_image] =>[orig_patent_app_number] => 11244481
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/244481 | Substituted pyridines having antiangiogenic activity | Oct 5, 2005 | Abandoned |
Array
(
[id] => 428689
[patent_doc_number] => 07268123
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-09-11
[patent_title] => 'Derivatives of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)alkyl]phosphonic acid and methods of making them'
[patent_app_type] => utility
[patent_app_number] => 11/244599
[patent_app_country] => US
[patent_app_date] => 2005-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11267
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/268/07268123.pdf
[firstpage_image] =>[orig_patent_app_number] => 11244599
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/244599 | Derivatives of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)alkyl]phosphonic acid and methods of making them | Oct 5, 2005 | Issued |
Array
(
[id] => 314870
[patent_doc_number] => 07524840
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-04-28
[patent_title] => '7,8-disubstituted pyrazolobenzodiazepines'
[patent_app_type] => utility
[patent_app_number] => 11/244251
[patent_app_country] => US
[patent_app_date] => 2005-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24002
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/524/07524840.pdf
[firstpage_image] =>[orig_patent_app_number] => 11244251
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/244251 | 7,8-disubstituted pyrazolobenzodiazepines | Oct 4, 2005 | Issued |
Array
(
[id] => 5614437
[patent_doc_number] => 20060116365
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-01
[patent_title] => 'Small molecule modulators of cytokine activity'
[patent_app_type] => utility
[patent_app_number] => 11/238285
[patent_app_country] => US
[patent_app_date] => 2005-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 29833
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0116/20060116365.pdf
[firstpage_image] =>[orig_patent_app_number] => 11238285
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/238285 | Small molecule modulators of cytokine activity | Sep 27, 2005 | Issued |
Array
(
[id] => 239616
[patent_doc_number] => 07592333
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-09-22
[patent_title] => 'Loxapine analogs and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/233417
[patent_app_country] => US
[patent_app_date] => 2005-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 53963
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/592/07592333.pdf
[firstpage_image] =>[orig_patent_app_number] => 11233417
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/233417 | Loxapine analogs and methods of use thereof | Sep 20, 2005 | Issued |
| 11/162737 | HYDROGENOLYTIC DENITRATION OF POLYNITRO COMPOUNDS: PENTANITROHEXAAZAISOWURTZITANE | Sep 20, 2005 | Abandoned |
Array
(
[id] => 5808350
[patent_doc_number] => 20060094705
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-04
[patent_title] => 'Quetiapine analogs and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/232565
[patent_app_country] => US
[patent_app_date] => 2005-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 54152
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0094/20060094705.pdf
[firstpage_image] =>[orig_patent_app_number] => 11232565
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/232565 | Quetiapine analogs and methods of use thereof | Sep 20, 2005 | Issued |